GT Healthcare Capital Partners

Type

Venture Capital

Status

Active

Location

Hong Kong, China

Total investments

24

Average round size

55M

Portfolio companies

13

Rounds per year

2.67

Lead investments

4

Follow on index

0.46

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceHealth CareMedical DeviceMedicalLife ScienceVirtual RealityPharmaceuticalTherapeuticsPsychology

Summary

In 2015 was created GT Healthcare Capital Partners, which is appeared as VC. The main department of described VC is located in the Hong Kong. The fund was located in Asia if to be more exact in Hong Kong.

The fund was created by Alan Au. Besides them, we counted 4 critical employees of this fund in our database.

The important activity for fund was in 2019. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The typical startup value when the investment from GT Healthcare Capital Partners is more than 1 billion dollars.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Oxford Nanopore Technologies, Oxford VR, Ultromics. The fund has specific favorite in a number of founders of portfolio startups.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the GT Healthcare Capital Partners, startups are often financed by Venrock, Sofinnova Partners, Pfizer Venture Investments. The meaningful sponsors for the fund in investment in the same round are Sonder Capital, Oxford Sciences Innovation, Vertex Ventures. In the next rounds fund is usually obtained by Oxford Finance LLC, Hostplus, GIC.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
24
Lead investments
4
Rounds per year
2.67
Follow on index
0.46
Investments by industry
  • Health Care (20)
  • Biotechnology (16)
  • Artificial Intelligence (7)
  • Medical Device (7)
  • Therapeutics (6)
  • Show 14 more
Investments by region
  • United Kingdom (12)
  • United States (8)
  • France (2)
  • China (2)
Peak activity year
2018
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
247M
Group Appearance index
0.92
Strategy success index
0.70

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
GT Apeiron Therapeutics 11 Jun 2019 Biotechnology, Health Care, Therapeutics Seed 27M Shanghai, China
WayRabbit 01 Mar 2016 Logistics, Information Technology, Mobile, Delivery, Shipping Seed United States, New York, New York
Potrero Medical 09 Jul 2018 Biotechnology, Artificial Intelligence, Health Care, Medical Device, Medical Late Stage Venture 26M United States, California, Hayward

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.